|
Index of reports
> All cases (114)
Below is the selection of adverse event reports related to Mobic (Meloxicam) that includes all cases.
Reports 1 - 25 of 114 Next >>
Adverse event in 62 year old male receiving Mobic (Meloxicam)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 62 year old male
Adverse reactions / side effects: Cataract, Orthostatic Hypotension, Headache, Posture Abnormal, Somnolence, Vision Blurred, Dizziness, Transient Ischaemic Attack, Asthenia
Suspect drug(s):
Mobic
Indication: Osteoarthritis
Start date: 2007-05-31
Study Drug
Indication: Osteoarthritis
Other drugs received by patient: Aspirin
Adverse event in female receiving Mobic (Meloxicam)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Fatigue, Palpitations, Arthralgia, Gastroenteritis Viral
Suspect drug(s):
Mobic (Meloxicam)
Other drugs received by patient: Theophylline; Hyzaar; Synthroid; Allegra D 24 Hour; Allopurinol; Alupent; Advair Diskus 100 / 50
Adverse event in female receiving Mobic (Meloxicam)
Reported by a physician from Japan on 2007-10-26
Patient: female, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Tuberculosis, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Remicade
Dosage: 9 infusions on unknown dates
Remicade
Dosage: 9 infusions on unknown dates
Remicade
Dosage: 9 infusions on unknown dates
Remicade
Dosage: 9 infusions on unknown dates
Remicade
Dosage: 9 infusions on unknown dates
Remicade
Dosage: 9 infusions on unknown dates
Remicade
Dosage: 9 infusions on unknown dates
Remicade
Dosage: 9 infusions on unknown dates
Remicade
Dosage: 9 infusions on unknown dates
Indication: Rheumatoid Arthritis
Mobic
Administration route: Oral
Indication: Rheumatoid Arthritis
Bredinin
Administration route: Oral
Indication: Rheumatoid Arthritis
Rimatil
Administration route: Oral
Indication: Rheumatoid Arthritis
Actonel
Administration route: Oral
Indication: Osteoporosis
Lansoprazole
Administration route: Oral
Indication: Reflux Oesophagitis
Cytotec
Dosage: 600rg
Administration route: Oral
Indication: Gastritis
Rheumatrex
Administration route: Oral
Indication: Rheumatoid Arthritis
Other drugs received by patient: Isoniazid
Adverse event in female receiving Mobic (Meloxicam)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Rash Pruritic
Suspect drug(s):
Mobic
Administration route: Oral
Indication: Arthritis
Start date: 2007-10-01
End date: 2007-10-01
Mobic
Indication: Synovial Cyst
Adverse event in female receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-10-23
Patient: female
Adverse reactions / side effects: Oedema Peripheral, Ankle Fracture, Fall
Adverse event resulted in: hospitalization
Suspect drug(s):
Mobic (Meloxicam)
Adverse event in male receiving Mobic (Meloxicam)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-23
Patient: male, weighing 100.0 kg (220.0 pounds)
Adverse reactions / side effects: Erythrosis, Cholestasis, Hepatic Failure, Upper Respiratory Tract Infection, Sleep Disorder, Gallbladder Disorder, Thrombocytopenia, Hypergammaglobulinaemia, Acute Prerenal Failure, Hepatitis Fulminant
Adverse event resulted in: hospitalization
Suspect drug(s):
Effexor XR
Dosage: unknown
Administration route: Oral
Indication: Depression
Start date: 2007-03-01
End date: 2007-09-01
Amlor
Administration route: Oral
End date: 2007-09-01
Mobic
Dosage: unknown
Administration route: Oral
Start date: 2007-07-01
End date: 2007-09-01
Contramal
Dosage: unknown
Administration route: Oral
Start date: 2007-07-01
End date: 2007-09-01
Other drugs received by patient: Levothyrox
Adverse event in male receiving Mobic (Meloxicam)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-19
Patient: male
Adverse reactions / side effects: Hepatic Failure, Hepatitis Fulminant
Adverse event resulted in: hospitalization
Suspect drug(s):
Contramal
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Mobic
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Effexor
Indication: Drug USE FOR Unknown Indication
Amlor
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Levothyroxine Sodium
Adverse event in 71 year old male receiving Mobic (Meloxicam)
Reported by a physician from Japan on 2007-10-19
Patient: 71 year old male, weighing 29.0 kg (63.8 pounds)
Adverse reactions / side effects: Arthritis Infective
Adverse event resulted in: hospitalization
Suspect drug(s):
Tacrolimus
Dosage: 1 mg, oral; 2 mg, oral
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2005-05-13
End date: 2005-06-09
Tacrolimus
Dosage: 1 mg, oral; 2 mg, oral
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2005-06-10
Mobic
Dosage: 10 mg, qod, oral
Administration route: Oral
Indication: Rheumatoid Arthritis
Adverse event in 73 year old female receiving Mobic (Meloxicam)
Reported by a individual with unspecified qualification from Taiwan, Province of China on 2007-10-19
Patient: 73 year old female
Adverse reactions / side effects: Ileal Perforation, Atrial Fibrillation, Septic Shock, Peritonitis
Adverse event resulted in: death
Suspect drug(s):
Aspirin
Administration route: Oral
Indication: Cardiovascular Event Prophylaxis
Start date: 2003-05-20
End date: 2007-10-03
Telmisartan
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-10
End date: 2007-10-03
Cortisone Acetate
Administration route: Oral
Indication: Adrenal Insufficiency
Start date: 2007-04-06
End date: 2007-10-03
Mobic
Administration route: Oral
Indication: Sciatica
Start date: 2007-09-12
End date: 2007-10-03
Flurbiprofen
Administration route: Oral
Indication: Back Pain
Start date: 2007-05-21
End date: 2007-10-03
Other drugs received by patient: Levothyroxine Sodium; Theophyliline; Lercanidipine; Bisoprolol Fumarate; Amiodarone HCL; Bumetanide
Adverse event in 75 year old female receiving Mobic (Meloxicam)
Reported by a individual with unspecified qualification from United States on 2007-10-17
Patient: 75 year old female
Adverse reactions / side effects: Transient Ischaemic Attack
Suspect drug(s):
Mobic
Indication: Osteoarthritis
Start date: 2007-02-06
End date: 2007-02-13
Mobic
Start date: 2007-02-13
End date: 2007-09-19
Study Drug
Indication: Osteoarthritis
Start date: 2007-01-22
End date: 2007-09-19
Other drugs received by patient: Benazepril Hydrochloride; Crestor; Alphagan; Nasonex; Travatan; Multi-Vitamin; Vitamin B-12
Adverse event in 55 year old male receiving Mobic (Meloxicam)
Reported by a individual with unspecified qualification from United States on 2007-10-17
Patient: 55 year old male
Adverse reactions / side effects: Arterial Occlusive Disease, Transient Ischaemic Attack
Adverse event resulted in: hospitalization
Suspect drug(s):
Mobic
Indication: Osteoarthritis
Start date: 2007-08-23
Study Drug
Indication: Osteoarthritis
Other drugs received by patient: Loratadine; Cetirizine+pseudoephedrine
Adverse event in 58 year old female receiving Mobic (Meloxicam)
Reported by a consumer/non-health professional from United States on 2007-10-15
Patient: 58 year old female, weighing 54.4 kg (119.7 pounds)
Adverse reactions / side effects: Aphthous Stomatitis
Suspect drug(s):
Lunesta
Dosage: 2 mg;prn;oral
Administration route: Oral
Indication: Insomnia
Start date: 2007-01-01
Lyrica
Indication: Nerve Injury
Start date: 2007-01-01
Mobic
Indication: Inflammation
Start date: 2007-01-01
Adverse event in female receiving Mobic (Meloxicam)
Reported by a consumer/non-health professional from United States on 2007-10-12
Patient: female
Adverse reactions / side effects: Hypersensitivity, DRY Mouth, Sneezing, Nasal Dryness
Suspect drug(s):
Mobic
Administration route: Oral
Indication: Inflammation
Start date: 2007-09-02
Mobic
Indication: Pain
Adverse event in receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-10-12
Patient:
Adverse reactions / side effects: Gastrointestinal Perforation
Adverse event resulted in: death
Suspect drug(s):
Mobic (Meloxicam)
Adverse event in female receiving Mobic (Meloxicam)
Reported by a consumer/non-health professional from United States on 2007-10-12
Patient: female
Adverse reactions / side effects: Fatigue, Palpitations, Arthralgia, Gastroenteritis Viral
Suspect drug(s):
Mobic (Meloxicam)
Other drugs received by patient: Theophylline; Hyzaar; Synthroid; Allegra D 24 Hour; Allopurinol; Alupent; Advair Diskus 100 / 50
Adverse event in 49 year old female receiving Mobic (Meloxicam)
Reported by a individual with unspecified qualification from United States on 2007-10-10
Patient: 49 year old female
Adverse reactions / side effects: Bladder Prolapse, Haematocrit Decreased, Haemorrhage, Post Procedural Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
Mobic
Administration route: Oral
Indication: Arthralgia
Start date: 2007-01-12
End date: 2007-06-19
Unknown Study Drug
Indication: Arthralgia
Start date: 2006-12-28
End date: 2007-07-09
Adverse event in female receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-10-08
Patient: female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Gastric Ulcer Haemorrhage
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Mobic (Meloxicam)
Adverse event in female receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-10-08
Patient: female
Adverse reactions / side effects: Haemorrhage, Haematoma
Adverse event resulted in: hospitalization
Suspect drug(s):
Mobic
Administration route: Oral
Plavix
Administration route: Oral
Aspirin
Administration route: Oral
Other drugs received by patient: Avapro; Lanoxin; Norvasc
Adverse event in female receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-10-04
Patient: female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Haemoptysis, Gastric Ulcer Haemorrhage
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Mobic (Meloxicam)
Adverse event in female receiving Mobic (Meloxicam)
Reported by a physician from Australia on 2007-10-03
Patient: female
Adverse reactions / side effects: Haemorrhage, Haematoma
Adverse event resulted in: hospitalization
Suspect drug(s):
Mobic
Administration route: Oral
Plavix
Administration route: Oral
Aspirin
Administration route: Oral
Other drugs received by patient: Avapro; Lanoxin; Norvasc
Adverse event in 57 year old male receiving Mobic (Meloxicam)
Reported by a consumer/non-health professional from United States on 2007-10-02
Patient: 57 year old male, weighing 108.0 kg (237.5 pounds)
Adverse reactions / side effects: Toxic Epidermal Necrolysis, Pharyngitis Streptococcal, Scar, Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Mobic (Meloxicam)
Adverse event in 67 year old female receiving Mobic (Meloxicam)
Reported by a physician from Japan on 2007-10-01
Patient: 67 year old female
Adverse reactions / side effects: Gingivitis, Pneumocystis Jiroveci Infection, Pneumonia Cytomegaloviral
Adverse event resulted in: hospitalization
Suspect drug(s):
Adalat
Administration route: Oral
Remicade
Indication: Rheumatoid Arthritis
Start date: 2004-10-21
Remicade
Start date: 2004-11-18
Rheumatrex
Rimatil
Administration route: Oral
Mobic
Mucosta
Administration route: Oral
Baylotensin
Administration route: Oral
Dibetos
Administration route: Oral
Catapres
Administration route: Oral
Glimicron
Administration route: Oral
Basen
Administration route: Oral
Methycobal
Administration route: Oral
Lipitor
Administration route: Oral
Other drugs received by patient: Predonine; Predonine; Predonine; Predonine; Predonine; Predonine; Predonine; Predonine; NU-Lotan; Insulin; Famotidine; Fangizone; Isodine; Diart; Clarithromycin; Ketoprofen; Simavastatin; Urso 250
Adverse event in female receiving Mobic (Meloxicam)
Reported by a physician from United States on 2007-10-01
Patient: female, weighing 118.8 kg (261.5 pounds)
Adverse reactions / side effects: Drug Toxicity, Atrial Fibrillation, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Zyflo
Dosage: (df)
Indication: Asthma
Start date: 2007-02-01
End date: 2007-02-01
Zyflo
Dosage: (df)
Indication: Status Asthmaticus
Start date: 2007-02-01
End date: 2007-02-01
Diovan
Dosage: (160 mg qd oral), (160 mg qd oral), (320 mg qd oral)
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
End date: 2007-02-01
Diovan
Dosage: (160 mg qd oral), (160 mg qd oral), (320 mg qd oral)
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-04-09
End date: 2007-06-15
Diovan
Dosage: (160 mg qd oral), (160 mg qd oral), (320 mg qd oral)
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2007-06-15
Benazepril HCL
Dosage: (40 mg bid), (40 mg qd)
Indication: Drug USE FOR Unknown Indication
End date: 2007-02-01
Mobic
Dosage: (7.5 mg, 1 dose qd prn)
Indication: Arthralgia
End date: 2007-02-01
Coumadin
Dosage: (3 mg 4x/week), (5 mg 3x/week)
Indication: Atrial Fibrillation
Prednisone
Other drugs received by patient: Toprol-XL; Avandia; Singulair; Quinine Sulfate; Advair Diskus 100 / 50; Protonix; Lipitor; Spiriva; Combivent; Alprazolam; Glucophage; Lasix; Cardizem CD; Melatonin; Ambien; Potassium Chloride; Insulin; Rhinocort; Macrobid; Wellbutrin; Theophylline; Multi-Vitamin; Nitroglycerin; Magnesium Sulfate; Hormones NOS; Lexapro; Aspirin
Adverse event in 55 year old female receiving Mobic (Meloxicam)
Reported by a health professional (non-physician/pharmacist) from Norway on 2007-07-31
Patient: 55 year old female
Adverse reactions / side effects: Vomiting, Anaemia, Faeces Discoloured, Haematemesis, Haemoglobin Decreased, Diarrhoea, C-Reactive Protein Increased, Bacterial DNA Test Positive, Duodenal Ulcer Haemorrhage, Melaena, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Voltaren
Dosage: 50 mg, tid
Indication: Back Pain
Start date: 2007-01-01
End date: 2007-07-10
Mobic
Dosage: 15 mg, bid
Administration route: Oral
End date: 2007-07-10
Other drugs received by patient: Surmontil; Paralgin Forte; Sobril; Sumatriptan Succinate
Adverse event in 70 year old male receiving Mobic (Meloxicam)
Reported by a physician from Japan on 2007-07-31
Patient: 70 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Sepsis, Liver Disorder, Stevens-Johnson Syndrome
Adverse event resulted in: death
Suspect drug(s):
Naproxen
Administration route: Oral
Indication: Pyrexia
Start date: 2006-09-20
End date: 2006-09-26
Rohypnol
Administration route: Oral
Start date: 2006-09-13
End date: 2006-09-15
Rohypnol
Administration route: Oral
Start date: 2006-09-18
End date: 2006-09-19
Rohypnol
Administration route: Oral
Start date: 2006-09-21
End date: 2006-09-21
Rohypnol
Administration route: Oral
Start date: 2006-09-23
End date: 2006-09-26
Cercine
Administration route: Oral
Indication: Convulsion Prophylaxis
Start date: 2006-09-24
End date: 2006-09-26
Perdipine
Dosage: dose increased or decreased based on blood pressure, on an as needed basis
Indication: Hypertension
Start date: 2006-08-24
End date: 2006-08-24
Amoban
Dosage: drug name: amoban tablets 7.5.
Administration route: Oral
Start date: 2006-09-20
End date: 2006-09-20
Amoban
Administration route: Oral
Start date: 2006-09-22
End date: 2006-09-23
Amoban
Administration route: Oral
Start date: 2006-09-25
End date: 2006-09-25
Magmitt
Administration route: Oral
Indication: Constipation
Start date: 2006-08-29
End date: 2006-09-26
Phenobarbital TAB
Administration route: Oral
Indication: Convulsion Prophylaxis
Start date: 2006-08-28
End date: 2006-09-23
Myslee
Administration route: Oral
Start date: 2006-08-22
End date: 2006-08-22
Myslee
Administration route: Oral
Start date: 2006-08-31
End date: 2006-08-31
Myslee
Administration route: Oral
Start date: 2006-09-23
End date: 2006-09-23
Ubretid
Administration route: Oral
Indication: Neurogenic Bladder
Start date: 2006-09-08
End date: 2006-09-29
Spelear
Administration route: Oral
Indication: Sputum Retention
Start date: 2006-09-14
End date: 2006-09-24
Selbex
Administration route: Oral
Indication: Gastritis
Start date: 2006-09-24
End date: 2006-09-24
Lansoprazole
Administration route: Oral
Indication: Gastric Ulcer
Start date: 2006-08-24
End date: 2006-08-24
Lansoprazole
Administration route: Oral
Start date: 2006-09-06
End date: 2006-09-29
Tegretol
Administration route: Oral
Indication: Wound Complication
Start date: 2006-09-22
End date: 2006-09-23
Aspirin
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2006-08-30
End date: 2006-09-30
Polaramine
Administration route: Oral
Indication: Pruritus
Start date: 2006-09-23
End date: 2006-09-23
Loxonin
Administration route: Oral
Indication: Wound Complication
Start date: 2006-09-18
End date: 2006-09-20
Loxonin
Administration route: Oral
Start date: 2006-09-23
End date: 2006-09-24
Voltaren
Indication: Wound Complication
Start date: 2006-08-24
End date: 2006-08-24
Voltaren
Dosage: form: rectal suppository.
Start date: 2006-09-04
Voltaren
Start date: 2006-09-17
End date: 2006-09-17
Voltaren
Start date: 2006-09-18
End date: 2006-09-19
Voltaren
Start date: 2006-09-20
End date: 2006-09-22
Voltaren
Start date: 2006-09-23
End date: 2006-09-23
Ketoprofen
Dosage: form: tape. dose: adjusted 10 x 14 cm.
Indication: Wound Complication
Start date: 2006-09-17
Laxoberon
Dosage: dose: as needed
Administration route: Oral
Indication: Constipation
Start date: 2006-09-02
Rinderon-VG
Dosage: dose: as needed
Administration route: Topical
Indication: Rash
Start date: 2006-09-18
Solu-Medrol
Indication: Asthma
Start date: 2006-09-20
End date: 2006-09-21
Aminofluid
Indication: Fluid Replacement
Start date: 2006-09-25
End date: 2006-09-26
Pasil
Indication: Infection
Start date: 2006-09-20
End date: 2006-09-20
Finibax
Indication: Infection
Start date: 2006-09-19
End date: 2006-09-20
Flumarin
Indication: Infection
Start date: 2006-09-17
End date: 2006-09-17
NEO-Minophagen C
Indication: Hepatic Function Abnormal
Start date: 2006-09-01
End date: 2006-09-11
NEO-Minophagen C
Start date: 2006-09-25
End date: 2006-09-27
NEO-Minophagen C
Start date: 2006-09-29
End date: 2006-10-12
Sennoside
Administration route: Oral
Indication: Constipation
Start date: 2006-08-22
End date: 2006-08-22
Humulin 70 / 30
Indication: Hyperglycaemia
Start date: 2006-08-23
End date: 2006-08-24
Mobic
Administration route: Oral
Start date: 2006-08-24
End date: 2006-08-24
Albumin (Human)
Start date: 2006-08-24
End date: 2006-08-24
1 Suspected Drug
Dosage: drug name reported as anapeine (ropivacaine)
Start date: 2006-08-24
End date: 2006-08-26
Omeprazole
Start date: 2006-08-24
End date: 2006-08-30
1 Suspected Drug
Dosage: drug name reported as pansporin (cefotiam hydrochloride)
Indication: Infection Prophylaxis
Start date: 2006-08-24
End date: 2006-08-26
Cataclot
Indication: Cerebral Infarction
Start date: 2006-08-24
End date: 2006-08-24
Multivitamin Additive
Dosage: total daily dose =1 vial
Indication: Vitamin Supplementation
Start date: 2006-08-24
End date: 2006-08-30
Novo-Heparin
Indication: Drug USE FOR Unknown Indication
Start date: 2006-08-24
End date: 2006-08-27
Bisolvon
Dosage: taken on an as needed basis
Start date: 2006-08-24
End date: 2006-08-24
Bisolvon
Dosage: taken on an as needed basis
Start date: 2006-08-29
End date: 2006-09-04
Radicut
Indication: Cerebral Infarction
Start date: 2006-08-24
End date: 2006-09-03
Amino Acid INJ
Indication: Nutritional Support
Start date: 2006-08-24
End date: 2006-08-25
Other drugs received by patient: Unspecified Drug
Page 1 Next >>
|
